Cargando…
Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription
BACKGROUND: Surgery combined with new adjuvant chemotherapy is the primary treatment for early stage invasive and advanced stage breast cancer. Growing evidence indicates that patients with ERα-positive breast cancer show poor response to chemotherapeutics. However, ERα-mediated drug-resistant mecha...
Autores principales: | Chen, Shuai, Wang, Han, Li, Zhi, You, Jun, Wu, Qiu-Wan, Zhao, Can, Tzeng, Chi-Meng, Zhang, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048156/ https://www.ncbi.nlm.nih.gov/pubmed/29937544 http://dx.doi.org/10.1038/s41416-018-0119-5 |
Ejemplares similares
-
Biosynthesis of the Pseudomonas aeruginosa common polysaccharide antigen by D-Rhamnosyltransferases WbpX and WbpY
por: Melamed, Jacob, et al.
Publicado: (2022) -
miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
por: Zou, Zhenyou, et al.
Publicado: (2017) -
The emerging roles of WBP2 oncogene in human cancers
por: Tabatabaeian, Hossein, et al.
Publicado: (2020) -
vhp Is a Fibrinogen-Binding Protein Related to vWbp in Staphylococcus aureus
por: Thomas, Sheila, et al.
Publicado: (2021) -
WBP2 shares a common location in mouse spermatozoa with WBP2NL/PAWP and like its descendent is a candidate mouse oocyte-activating factor
por: Hamilton, Lauren E, et al.
Publicado: (2018)